Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sclerosing cholangitis.

George R MacFaul1, Roger W Chapman

  • 1Department of Gastroenterology, John Radcliffe Hospital, Oxford, United Kingdom.

Current Opinion in Gastroenterology
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determining the time to cholangiocarcinoma in pediatric-onset PSC-IBD.

Journal of pediatric gastroenterology and nutrition·2024
Same author

Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD.

Endoscopy international open·2024
Same author

Primary sclerosing cholangitis-A long night's journey into day.

Clinical liver disease·2022
Same author

Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.

Liver international : official journal of the International Association for the Study of the Liver·2020
Same author

Review of primary sclerosing cholangitis with increased IgG4 levels.

World journal of gastroenterology·2020
Same author

Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.

Clinical medicine (London, England)·2020
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Primary sclerosing cholangitis (PSC) is a chronic liver disease linked to inflammatory bowel disease. High-dose ursodeoxycholic acid may slow fibrosis and reduce colorectal cancer risk in PSC patients.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Immunology

Background:

  • Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with biliary tree strictures.
  • PSC is strongly associated with inflammatory bowel disease, especially ulcerative colitis, but its cause is unknown.
  • The increasing prevalence of PSC necessitates greater attention in secondary care settings.

Purpose of the Study:

  • To review current research on the etiopathogenesis, epidemiology, and management of PSC.
  • To discuss associations between PSC and other cancers, including cholangiocarcinoma and colorectal carcinoma.
  • To evaluate medical therapies and liver transplantation outcomes for PSC.

Main Methods:

  • Literature review of recent research on PSC.

Related Experiment Videos

  • Analysis of studies on small-duct vs. large-duct PSC.
  • Evaluation of therapeutic interventions including ursodeoxycholic acid, endoscopic therapy, and liver transplantation.

    • Main Results:

    • Small-duct PSC has a favorable prognosis compared to large-duct PSC.
    • Gallbladder cancer incidence is elevated in PSC patients; screening and cholecystectomy for polyps are advised.
    • High-dose ursodeoxycholic acid shows potential in slowing liver fibrosis and reducing colorectal cancer risk in PSC patients with ulcerative colitis.

    Conclusions:

    • Small-duct PSC is a distinct entity with a better prognosis.
    • Yearly screening for gallbladder cancer and colon cancer in patients with PSC and IBD is recommended.
    • While liver transplant is curative for end-stage PSC, recurrence is a significant concern, alongside post-transplant colorectal cancer risk.